Statistics

Total Visits

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The8

Select a period of time:

Number of views in the range

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The2

Views

Views
May 20240
June 20240
July 20240
August 20240
September 20242
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
 

Top cities views

Views